Moderna, Inc. (MRNA)

NasdaqGS • Currently up 19.94 (+14.36%) in today's trading session

3 members of Congress have disclosed 6 trades in Moderna, Inc. (MRNA) via STOCK Act filings. The most recent disclosure was a sale by Robert P. Bresnahan on 8 April 2025. The most active traders have been Josh Gottheimer (3), Robert P. Bresnahan (2), and Julie Johnson (1). Aggregate disclosed activity totals roughly $16K in purchases and $32K in sales (midpoint estimates from bracketed disclosure amounts).

Moderna, Inc. is currently trading at $158.83, positioned at 88% of its 52-week range ($22.28 – $176.66).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Portfolio

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$158.83
24h Change
+19.94 (+14.36%)
52 Week Range
$22.28—$176.66
View on NASDAQ

Moderna, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for MRNA

Select to highlight on chart
6 transactions
Compliance: 100%
Robert P. Bresnahan8 Apr 20258 May 2025SaleStock$1,001 - $15,000N/A
Robert P. Bresnahan25 Feb 202527 Mar 2025PurchaseStock$1,001 - $15,000N/A
Julie Johnson15 Jan 202512 Feb 2025SaleStock$1,001 - $15,000N/A
Josh Gottheimer1 Feb 20247 Mar 2024SaleStock$1,001 - $15,000N/A
Josh Gottheimer31 Mar 202320 Apr 2023PurchaseStock$1,001 - $15,000N/A
Josh Gottheimer22 May 202010 Jun 2020SaleStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$63.02B

Volume

49.05M

Beta

0.90

P/E Ratio

-19.49

Fundamentals

EPS

$-8.15

Div. Yield

—

Open

$143.41

Day Range

$141.21 — $161.37

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Stéphane Bancel
IPO Date
2018-12-07
Website
www.modernatx.com

Moderna, Inc., a biotechnology firm, is dedicated to the discovery, development, and commercialization of messenger RNA (mRNA) based therapies and preventive medicines. Its extensive research and development efforts target a broad spectrum of medical...

Earnings

Next Report

Q3 2026

5 Nov

EPS Est.

$-1.40

Rev. Est.

$872.9M

Days Until

71

Recent Quarters

Q2 202631 Jul
EPS$-1.97
Beat 3.0%
Q1 20261 May
EPS$-3.40
Beat 23.6%
Q4 202513 Feb
EPS$-2.11
Beat 16.9%
Q3 20256 Nov
EPS$-0.51
Beat 72.7%
Q2 20251 Aug
EPS$-2.13
Beat 28.8%
Q1 20251 May
EPS$-2.52
Beat 13.7%
Q4 202414 Feb
EPS$-2.50
Beat 6.7%
Q3 20247 Nov
EPS$0.03
Beat 101.6%
Q2 20241 Aug
EPS$-3.33
Beat 0.6%
Q1 20242 May
EPS$-3.07
Beat 13.8%
Q4 202322 Feb
EPS$0.55
Beat 156.7%
Q3 20232 Nov
EPS$-9.53
Miss 393.2%
Q2 20233 Aug
EPS$-3.62
Beat 5.7%
Q1 20234 May
EPS$0.19
Beat 110.7%
Q4 202223 Feb
EPS$3.61
Miss 22.9%
Q3 20223 Nov
EPS$2.53
Miss 23.1%
Q2 20223 Aug
EPS$5.24
Beat 15.2%
Q1 20224 May
EPS$8.58
Beat 64.7%
Q4 202124 Feb
EPS$11.29
Beat 14.0%
Q3 20214 Nov
EPS$7.70
Miss 14.9%
Q2 20215 Aug
EPS$6.46
Beat 8.4%
Q1 20216 May
EPS$2.84
Beat 18.8%
Q4 202025 Feb
EPS$-0.69
Miss 176.0%
Q3 202029 Oct
EPS$-0.59
Miss 37.2%
Q2 20205 Aug
EPS$-0.31
Beat 13.9%
Q1 20207 May
EPS$-0.35
Beat 5.4%
Q4 201926 Feb
EPS$-0.37
Beat 13.9%
Q3 20196 Nov
EPS$-0.37
Beat 13.9%
Q2 20197 Aug
EPS$-0.41
Beat 2.4%
Q1 20199 May
EPS$-0.40
Miss 14.3%
Q4 20186 Mar
EPS$-1.78
Miss 394.4%
Q3 20187 Dec
EPS$-0.23
Q2 201830 Sept
EPS$-0.25
Q4 201731 Mar
EPS$-0.18
Q3 201731 Dec
EPS$-0.13
Q2 201730 Sept
EPS$-1.05
Q1 201730 Jun
EPS$-1.25
Q4 201631 Mar
EPS$-1.25

3 politicians traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about MRNA

Which members of Congress have traded MRNA?
3 members of Congress have disclosed 6 trades in Moderna, Inc. (MRNA) under the STOCK Act. The most active traders are Josh Gottheimer, Robert P. Bresnahan, and Julie Johnson.
When was MRNA most recently disclosed by Congress?
The most recent MRNA disclosure was a sale by Robert P. Bresnahan on 8 April 2025.
What is the total disclosed congressional trading volume for MRNA?
Members of Congress have disclosed approximately $16K in MRNA purchases and $32K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in MRNA?
This MRNA page updates as soon as new STOCK Act disclosures are filed for Moderna, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.